Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
India
/
Pharmaceuticals & Biotech
Create a narrative
Divi's Laboratories
NSEI:DIVISLAB Community
1
Narratives
written by author
0
Comments
on narratives written by author
29
Fair Values set
on narratives written by author
Create a narrative
Divi's Laboratories
Popular
Undervalued
Overvalued
Divi's Laboratories
WA
Analyst Price Target
Consensus Narrative from 28 Analysts
Investments In Peptide Synthesis And Continuous Flow Chemistry Will Boost Capacity And Efficiency
Key Takeaways Strategic investments in peptide synthesis and greenfield expansion enhance future revenue potential through capacity and product line growth. Backward integration and continuous flow chemistry aim to improve margins, boosting supply chain resilience and operational efficiency.
View narrative
₹5.51k
FV
4.4% overvalued
intrinsic discount
16.90%
Revenue growth p.a.
Set as Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
2 months ago
author updated this narrative
Your Valuation for
DIVISLAB
Divi's Laboratories
Your Fair Value
₹
Current Price
₹5.76k
11.6% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
191b
2015
2018
2021
2024
2025
2027
2030
Revenue ₹190.7b
Earnings ₹43.4b
Advanced
Set as Fair Value